Dark
Light
Today: November 7, 2024
February 14, 2024
1 min read

Building a €173M Nest Egg: Early Birds Boosting European Healthcare

TLDR: European venture capital firm Earlybird has closed a €173 million healthcare fund to support European healthcare companies. The fund will target companies across digital health, diagnostics, medical devices, R&D tools, and biopharma sectors. Earlybird will utilize its AI tool, Earlybird Eagle Eye, to identify and gather information on new startups. Institutional investors such as British Patient Capital and BARMER participated in the fund. Earlybird currently supports biotech companies including Ariceum Therapeutics, Grey Wolf Therapeutics, ImCheck Therapeutics, Oculis, and Priothera.

Previous Story

Motif Neurotech: Fueling Success with $1875M in Initial Funding

Next Story

Earlybird Health: Doubling Down on Funding for Bigger Opportunities

Latest from Blog

Go toTop